JPMorgan Chase & Co’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
210,122
-96,302
| -31% | -$119K | ﹤0.01% | 4349 |
|
|
2025
Q1 | $374K | Buy |
306,424
+14,628
| +5% | +$17.8K | ﹤0.01% | 4173 |
|
|
2024
Q4 | $525K | Buy |
291,796
+279,020
| +2,184% | +$502K | ﹤0.01% | 4122 |
|
|
2024
Q3 | $65K | Buy |
12,776
+9,672
| +312% | +$49.2K | ﹤0.01% | 4899 |
|
|
2024
Q2 | $22.1K | Buy |
+3,104
| New | +$22.1K | ﹤0.01% | 5125 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$3 | – | 6718 |
|
|
2023
Q4 | $3 | Buy |
+1
| New | +$3 | ﹤0.01% | 6423 |
|
|
2022
Q2 | – | Sell |
-2,829
| Closed | -$24K | – | 5951 |
|
|
2022
Q1 | $24K | Sell |
2,829
-205,199
| -99% | -$1.74M | ﹤0.01% | 5237 |
|
|
2021
Q4 | $2.18M | Buy |
208,028
+4,590
| +2% | +$48K | ﹤0.01% | 3177 |
|
|
2021
Q3 | $3.66M | Buy |
+203,438
| New | +$3.66M | ﹤0.01% | 2799 |
|